Transcription factor (TF)-mediated reprogramming to pluripotency is a slow and inefficient process, because most pluripotency TFs fail to access relevant target sites in a refractory chromatin environment. It is still unclear how TFs actually orchestrate the opening of repressive chromatin during the long latency period of reprogramming. Here, we show that the orphan nuclear receptor Esrrb plays a pioneering role in recruiting the core pluripotency factors Oct4, Sox2, and Nanog to inactive enhancers in closed chromatin during the reprogramming of epiblast stem cells. Esrrb binds to silenced enhancers containing stable nucleosomes and hypermethylated DNA, which are inaccessible to the core factors. Esrrb binding is accompanied by local loss of DNA methylation, LIF-dependent engagement of p300, and nucleosome displacement, leading to the recruitment of core factors within approximately 2 days. These results suggest that TFs can drive rapid remodeling of the local chromatin structure, highlighting the remarkable plasticity of stable epigenetic information.
Pubmed ID: 29910149 RIS Download
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.
This monoclonal targets CD31
View all literature mentionsThis monoclonal targets FLAG
View all literature mentionsThis polyclonal targets TET1
View all literature mentionsThis polyclonal targets SOX2
View all literature mentionsThis polyclonal targets POU5F1
View all literature mentionsThis monoclonal targets Phospho-Stat3 (Tyr705)
View all literature mentionsThis monoclonal targets alpha-Tubulin
View all literature mentionsThis polyclonal targets Human SOX17
View all literature mentionsThis monoclonal targets Oct-3/4
View all literature mentionsThis polyclonal targets Mouse KLF4
View all literature mentionsThis monoclonal targets Human SALL4
View all literature mentionsThis polyclonal targets Mouse DPPA4 Affinity Purified Ab
View all literature mentionsThis polyclonal targets monomeric Kusabira-Orange 2
View all literature mentionsThis monoclonal targets Nanog
View all literature mentionsThis monoclonal targets Human ERR beta
View all literature mentionsVisualize and analyze data generated by all of Illumina''s platforms.
View all literature mentions